Want to see PDEX full AI Analyst Report?
Revenue by Segment
Highlights revenue from different business segments, revealing which areas are driving growth and which may need strategic adjustments.Orthopedic has become the company’s clear growth engine after a sharp inflection in late‑2024, driving most recent top‑line momentum and increasing revenue concentration risk; CMF is volatile but appears to be grinding toward recovery, while Thoracic is inconsistent and losing share, suggesting product or market headwinds (or deprioritization). For investors, the key questions are whether Orthopedic’s lift is durable and margin accretive, and whether management will reinvest to stabilize CMF/Thoracic or double down on Orthopedic scale.
Date | Orthopedic | CMF | Thoracic |
|---|---|---|---|
Jun 30, 2026 | $12.79M | $2.69M | $814.00K |
Mar 31, 2026 | $13.07M | $2.61M | $563.00K |
Dec 31, 2025 | $11.88M | $3.10M | $183.00K |
Sep 30, 2025 | $11.05M | $2.83M | $501.00K |
Jun 30, 2025 | $8.91M | $3.55M | $1.23M |
Mar 31, 2025 | $8.61M | $2.35M | $952.00K |
Dec 31, 2024 | $9.33M | $1.84M | $1.06M |
Sep 30, 2024 | $6.70M | $2.20M | $1.02M |
Jun 30, 2024 | $6.49M | $3.69M | $256.00K |
Mar 31, 2024 | $6.76M | $2.25M | $770.00K |